Contributor

Bruno Occhipinti

Bruno Occhipinti

Bruno Occhipinti, MBA, MA, MSc

CEO of Qritive

Bruno Occhipinti is CEO of Qritive, a Singaporean start-up specialized in AI-powered solutions for affordable and accurate cancer diagnostics at scale. Previously, he was General Manager of AICS (ASUS) focusing on healthcare transformation through artificial intelligence. He also founded CrestaLab, a boutique consulting firm to advise corporations leveraging digital solutions for health equity. Formerly in Philips, he was Director of Strategy and New Business Development, and designed and executed initiatives in chronic-care management and affordable care across Southeast Asia. He also worked in strategy and business development roles at Philips HQ in the Netherlands, Samsung Korea, and Hyperion Solutions in France and Singapore. He holds his MBA from Wharton.